PharmaCyte Biotech Inc (PMCB)

[1234jklm]

It could be because he is getting old and doesn't have the energy to see it through.

Isn't this why Makowka is being brought onboard...and also perhaps as a monitor for future iview investment. The company needs millions for the pivotal trial and Makowka being at the pre ind meeting suggests iview are monitoring the process before buying from chardin as part of the ATM 50 million funding which is in place.

Let's hope the share price doesn't go too low in the meantime so dilution isn't too high. The cheaper the share price the more shares an investor gets for their investment.

A good reason to keep it below 10 cents perhaps?

Once that investment is made the pps should go through the roof with no reason to keep it low.

Load up now.